2,3-diaminopyridine bradykinin B1 receptor antagonists
- PMID: 15588075
- DOI: 10.1021/jm049394l
2,3-diaminopyridine bradykinin B1 receptor antagonists
Abstract
Bradykinin B1 receptor antagonists embody a potentially novel approach for the treatment of chronic pain and inflammation. A series of 2,3-diaminopyridine B1 antagonists was optimized to have sub-nanomolar affinity and good pharmacokinetic properties. Lead compounds were shown to exhibit good efficacy in rabbit in vivo models of pain and inflammation.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information